Indian Journal of Pharmaceutical Education and Research logo
Submit
Indian Journal of Pharmaceutical Education and ResearchAn Official Publication of Association of Pharmaceutical Teachers of India (APTI)
Article

The Prevalence of Anemia and Hematological Findings in COVID-19 Patients in Saudi Arabia

1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 5, 3, 1, 4

  1. 1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, SAUDI ARABIA.
  2. 2Department of Chemistry, College of Sciences, Taif University, Taif, SAUDI ARABIA.
  3. 3Department of Internal Medicine, Section of Infectious Diseases, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAUDI ARABIA.
  4. 4Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Jazan, SAUDI ARABIA.
  5. 5Department of Clinical Laboratory, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAUDI ARABIA.

CORRESPONDENCE

Mazen Almehmadi

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, SAUDI ARABIA.

tdr.mazen.ma@gmail.com

Received: 17-11-2021; Accepted: 07-07-2022.

Volume 56, Issue 4 · pp. 1226-1231 · 2022 · DOI: 10.5530/ijper.56.4.204

ABSTRACT

Objectives: The aim of this study was to estimate the prevalence of anemia among COVID-19 patients in Saudi Arabia and evaluate their hematological parameters.Materials and Methods: A descriptive, cross-sectional, hospital-based study was conducted between February 2021 to March 2021, data collection covered the period between September 2020 to March 2021. All the patients were hospitalized for confirmed COVID-19.Results: A total of 6048 COVID-19 patients included in our study, 2358 (48.9%) were anemic, 3666 (60.61%) were normal HGB level, and only 24 (0.49%) were having polycythemia. Hemoglobin level ranged from 5 g/dL to 18 g/dL with a median (interquartile range) of 11.8 g/dL (8.9 to 13.1) g/dL. The median for male (interquartile range) was for anemic patient’s 9.8 g/dL (8.5 to 11.4) g/dL, normal 14 g/dL (13.5 to 14.8) g/dL, and polycythemia 17.4 g/dL (17.2 to 17.7) g/dL. The median for female (interquartile range) was for anemic patient’s 9.1 g/dL (8.2 to 10.2) g/dL, normal 13.5 g/ dL (12.5 to 14.5) g/dL, and polycythemia 17 g/dL (16.82 to 17.2) g/dL. Hematological parameters detected are indicative of severe complications in anemic patients compared to non-anemic patients.Conclusion: Our findings were consistent with other studies that reported poor outcomes of anemia in COVID-19 patients.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Almehmadi, M., Salih, M., Al-hazmi, A., Alenazi, M., Abdulaziz, O., Almalki, F., Shafie, A., Alsiwiehri, N., Allahyani, M., Althibity, N., Alosimi, E., Turjoman, A., Rebh, F., Aljuaid, A., & Halawi, M. (2022). The Prevalence of Anemia and Hematological Findings in COVID-19 Patients in Saudi Arabia. Indian Journal of Pharmaceutical Education and Research, 56(4), 1226-1231. https://doi.org/10.5530/ijper.56.4.204

    Copyright and licence

    © 2022 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0